 | • レポートコード：MRC2302A061P • 出版社/出版日：360iResearch / 2023年2月1日 • レポート形態：英語、PDF、258ページ • 納品方法：Eメール（受注後3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社発行の当調査レポートでは、2021年に263億ドルであった世界の画像診断装置市場規模が、2022年に278.5億ドルに達し、2027年には375.1億ドルまで年平均6.09％で成長すると予測しています。当レポートは、画像診断装置の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、モダリティ別（CT、MRI装置、マンモグラフィ装置、核医学画像診断装置、超音波画像診断装置）分析、エンドユーザー別（診断センター、病院）分析、用途別（循環器内科、消化器科、婦人科、神経科、その他）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でまとめております。なお、当書には、Agfa–Gevaert N.V.、Arterys Inc.、Canon Inc.、Caption Health, Inc.、Carestream Health、CellmatiQ GmbH、CurveBeam LLC、Esaote SPA、FUJIFILM Holdings Corporation、GE Healthcare、Hologic, Inc.、Koninklijke Philips N.V.、Mindray Medical International Limited、Planmed Oyなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の画像診断装置市場規模：モダリティ別 - CTの市場規模 - MRI装置の市場規模 - マンモグラフィ装置の市場規模 - 核医学画像診断装置の市場規模 - 超音波画像診断装置の市場規模 ・世界の画像診断装置市場規模：エンドユーザー別 - 診断センターにおける市場規模 - 病院における市場規模 ・世界の画像診断装置市場規模：用途別 - 循環器内科における市場規模 - 消化器科における市場規模 - 婦人科における市場規模 - 神経科における市場規模 - その他用途における市場規模 ・世界の画像診断装置市場規模：地域別 - 南北アメリカの画像診断装置市場規模 アメリカの画像診断装置市場規模 カナダの画像診断装置市場規模 ブラジルの画像診断装置市場規模 ... - アジア太平洋の画像診断装置市場規模 日本の画像診断装置市場規模 中国の画像診断装置市場規模 インドの画像診断装置市場規模 韓国の画像診断装置市場規模 台湾の画像診断装置市場規模 ... - ヨーロッパ/中東/アフリカの画像診断装置市場規模 イギリスの画像診断装置市場規模 ドイツの画像診断装置市場規模 インドの画像診断装置市場規模 フランスの画像診断装置市場規模 ロシアの画像診断装置市場規模 ... - その他地域の画像診断装置市場規模 ・競争状況 ・企業情報 |
The Global Diagnostic Imaging Market size was estimated at USD 26.30 billion in 2021 and expected to reach USD 27.85 billion in 2022, and is projected to grow at a CAGR 6.09% to reach USD 37.51 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Diagnostic Imaging to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Modality, the market was studied across Computed Tomography, MRI Systems, Mammography Systems, Nuclear Imaging Systems, Ultrasound Imaging Systems, and X-Ray Imaging Systems. The Computed Tomography is further studied across High End Scanners (128-Slice and More), Low End Scanners (~16-Slice), and Mid Range Scanners (~64-Slice). The MRI Systems is further studied across High field MRI systems (1.5-3 T), Low and mid field MRI systems (<1.5 T), and Very High, and Ultra High Field MRI Systems (3T and more). The Ultrasound Imaging Systems is further studied across 2D Ultrasound, 3D and 4D Ultrasound, and Doppler Ultrasound. The X-Ray Imaging Systems is further studied across Analog Systems and Digital Systems. Based on End-User, the market was studied across Diagnostic Centers and Hospitals. Based on Application, the market was studied across Cardiology, Gastroenterology, Gynecology, Neurology, Oncology, and Orthopedics. Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market. Cumulative Impact of 2022 Russia Ukraine Conflict: We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Diagnostic Imaging market considering the current update on the conflict and its global response. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Diagnostic Imaging Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Competitive Scenario: The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service. Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Diagnostic Imaging Market, including Agfa–Gevaert N.V., Arterys Inc., Canon Inc., Caption Health, Inc., Carestream Health, CellmatiQ GmbH, CurveBeam LLC, Esaote SPA, FUJIFILM Holdings Corporation, GE Healthcare, Hologic, Inc., Koninklijke Philips N.V., Mindray Medical International Limited, Planmed Oy, Samsung Electronics Co., Ltd., Shimadzu Corporation, and Siemens Healthineers AG. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Diagnostic Imaging Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Diagnostic Imaging Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Diagnostic Imaging Market? 4. What is the competitive strategic window for opportunities in the Global Diagnostic Imaging Market? 5. What are the technology trends and regulatory frameworks in the Global Diagnostic Imaging Market? 6. What is the market share of the leading vendors in the Global Diagnostic Imaging Market? 7. What modes and strategic moves are considered suitable for entering the Global Diagnostic Imaging Market?
レポート目次1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing geriatric population and the subsequent increase in the prevalence of associated diseases
5.1.1.2. Technological advancements in diagnostic imaging modalities coupled with the need for early diagnosis
5.1.1.3. Growing investments, funds, and grants by public-private organizations
5.1.2. Restraints
5.1.2.1. High cost of diagnostic imaging systems and growing regulatory burden in the U.S.
5.1.3. Opportunities
5.1.3.1. Adoption of artificial intelligence and analytics in diagnostic imaging
5.1.3.2. Use of blockchain in diagnostic imaging
5.1.3.3. Growing adoption of teleradiology and mobile solutions
5.1.4. Challenges
5.1.4.1. Increasing adoption of refurbished diagnostic imaging systems and a dearth of trained professionals
5.2. Cumulative Impact of COVID-19
6. Diagnostic Imaging Market, by Modality
6.1. Introduction
6.2. Computed Tomography
6.3.1. High End Scanners (128-Slice and More)
6.3.2. Low End Scanners (~16-Slice)
6.3.3. Mid Range Scanners (~64-Slice)
6.3. MRI Systems
6.4.1. High field MRI systems (1.5-3 T)
6.4.2. Low and mid field MRI systems (<1.5 T)
6.4.3. Very High, and Ultra High Field MRI Systems (3T and more)
6.4. Mammography Systems
6.5. Nuclear Imaging Systems
6.6. Ultrasound Imaging Systems
6.7.1. 2D Ultrasound
6.7.2. 3D and 4D Ultrasound
6.7.3. Doppler Ultrasound
6.7. X-Ray Imaging Systems
6.8.1. Analog Systems
6.8.2. Digital Systems
7. Diagnostic Imaging Market, by End-User
7.1. Introduction
7.2. Diagnostic Centers
7.3. Hospitals
8. Diagnostic Imaging Market, by Application
8.1. Introduction
8.2. Cardiology
8.3. Gastroenterology
8.4. Gynecology
8.5. Neurology
8.6. Oncology
8.7. Orthopedics
9. Americas Diagnostic Imaging Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Diagnostic Imaging Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Diagnostic Imaging Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Agfa–Gevaert N.V.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Arterys Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Canon Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Caption Health, Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Carestream Health
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. CellmatiQ GmbH
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. CurveBeam LLC
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Esaote SPA
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. FUJIFILM Holdings Corporation
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. GE Healthcare
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Hologic, Inc.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Koninklijke Philips N.V.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Mindray Medical International Limited
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Planmed Oy
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Samsung Electronics Co., Ltd.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Shimadzu Corporation
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Siemens Healthineers AG
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing